Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Great Falls, MT
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Missoula, MT
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Missoula, MT
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Bellevue, NE
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Bellevue, NE
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Bellevue, NE
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Lincoln, NE
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lincoln, NE
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Omaha, NE
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Omaha, NE
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Omaha, NE
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Las Vegas, NV
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Las Vegas, NV
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Edison, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Edison, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Edison, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Edison, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Livingston, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Livingston, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Marlton, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Marlton, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Northfield, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Northfield, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Somerville, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Somerville, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Verona, NJ
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Verona, NJ
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Albuquerque, NM
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Albuquerque, NM
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Astoria, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Astoria, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Great Neck, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Great Neck, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Johnson City, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Johnson City, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Newburgh, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Newburgh, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
North Syracuse, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
North Syracuse, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Staten Island, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Utica, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Utica, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Westfield, NY
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Westfield, NY
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Asheboro, NC
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Asheboro, NC
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Asheville, NC
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Asheville, NC
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Clyde, NC
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Clyde, NC
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
High Point, NC
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Shelby, NC
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Shelby, NC
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Fargo, ND
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Fargo, ND
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Akron, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Beavercreek, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Beavercreek, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Canton, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Cincinnati, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Cleveland, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dayton, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Dayton, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Marion, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Marion, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Shaker Heights, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Shaker Heights, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Sylvania, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Sylvania, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Toledo, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Toledo, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Wheeling, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Wheeling, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Zanesville, OH
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Zanesville, OH
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated:  12/31/1969
GSK Investigational Site
mi
from
Ashland, OR
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma
Status: Enrolling
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ashland, OR
Click here to add this to my saved trials